Amazed by the cynicism of some on here. How can evidence of durable benefit be repeat news? There is a huge difference between short term PSA suppression & potential longer term cure?
The timing is more likely a reflection of the company being strategic about the timing of the raise (in between news with significant catalysts ahead) rather than them doing any brokers a favour
Ann: Complete response with Cu-67 SAR-bisPSMA, page-29
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$8.20 |
Change
-0.535(6.13%) |
Mkt cap ! $2.659B | |||
| Open | High | Low | Value | Volume |
| $8.62 | $8.68 | $8.19 | $5.689M | 675.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 6387 | $8.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $8.20 | 1518 | 9 |
View Market Depth
| Last trade - 13.56pm 04/10/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |